Tyler Lipschultz

Tyler has over 35 years of leadership experience in orthopaedics, spine, and biologics. Most recently, he was President, Global Biologics at Orthofix and SeaSpine’s SVP of Biologics and Business Development prior to the SeaSpine-Orthofix merger. Tyler was also an SLT member and SVP at NuVasive, where he initially led Biologics and then Global Operations. Earlier in his career, Tyler held various positions at Spine Wave/VERTx, DePuy, Smith & Nephew, Stryker and Piper Jaffray where he was an equity research analyst. Tyler earned a BA in Economics from Kalamazoo College and an MBA from the Krannert School of Business at Purdue University.